Literature DB >> 19675772

Primary hyperoxaluria and systemic oxalosis.

K Sriram1, Nitin S Kekre, Ganesh Gopalakrishnan.   

Abstract

Entities:  

Year:  2007        PMID： 19675772      PMCID： PMC2721506          DOI： 10.4103/0970-1591.30276

Source DB:  PubMed          Journal:  Indian J Urol        ISSN： 0970-1591


× No keyword cloud information.
  4 in total

1.  International registry for primary hyperoxaluria.

Authors:  John C Lieske; Carla G Monico; W Scott Holmes; Erik J Bergstralh; Jeffrey M Slezak; Audrey L Rohlinger; Julie B Olson; Dawn S Milliner
Journal:  Am J Nephrol       Date:  2005-06-15       Impact factor: 3.754

Review 2.  Molecular etiology of primary hyperoxaluria type 1: new directions for treatment.

Authors:  Christopher J Danpure
Journal:  Am J Nephrol       Date:  2005-06-15       Impact factor: 3.754

3.  Radiological aspects of primary hyperoxaluria.

Authors:  D L Day; J I Scheinman; J Mahan
Journal:  AJR Am J Roentgenol       Date:  1986-02       Impact factor: 3.959

4.  Soft-tissue calcifications: differential diagnosis and therapeutic approaches.

Authors:  J Hussmann; R C Russell; J O Kucan; R Khardori; H U Steinau
Journal:  Ann Plast Surg       Date:  1995-02       Impact factor: 1.539
  4 in total
  3 in total

1.  Bone Marrow Oxalosis: Crystal Flowers in the Bone Marrow Garden

Authors:  Nabhajit Mallik; Man Updesh Singh Sachdeva
Journal:  Turk J Haematol       Date:  2020-10-16       Impact factor: 1.831

2.  Chronic liver disease and hepatic calcium-oxalate deposition in patients with primary hyperoxaluria type I.

Authors:  Pia Recker; Bodo Bernhard Beck; Przemyslaw Sikora; Heike Göbel; Markus Josef Kemper; Angel Nazco; Cristina Martin-Higueras; Bernd Hoppe
Journal:  Sci Rep       Date:  2022-10-06       Impact factor: 4.996

3.  A comprehensive analysis of sialolith proteins and the clinical implications.

Authors:  Carlos S Busso; Jessie J Guidry; Jhanis J Gonzalez; Vassilia Zorba; Leslie S Son; Peter J Winsauer; Rohan R Walvekar
Journal:  Clin Proteomics       Date:  2020-03-31       Impact factor: 3.988
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.